Pregabalin Completed Phase 3 Trials for Seizures Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00143130Pregabalin In Partial Seizures Extension Study